Sort   by:  
 Page size 
UnknownEffects of Sex, Existing Antibodies, and HIV-1-Related and Other Baseline Factors on Antibody Responses to Quadrivalent HPV Vaccine in Persons With HIV.
Not available
S-EPMC8881300 | biostudies-literature
UnknownWin Ratio Aligns With and Enhances Interpretation of REPRIEVE's Primary Findings.
Not available
S-EPMC12477884 | biostudies-literature
UnknownCOVID-19 Vaccination Rates in a Global HIV Cohort.
Not available
S-EPMC8844595 | biostudies-literature
UnknownMortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067.
Not available
S-EPMC11494148 | biostudies-literature
UnknownPhysical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
Not available
S-EPMC7347078 | biostudies-literature
UnknownImpact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.
Not available
S-EPMC3491848 | biostudies-literature
UnknownThe incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin.
Not available
S-EPMC3184244 | biostudies-literature
UnknownPNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
Not available
S-EPMC6408225 | biostudies-literature
UnknownPerformance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.
Not available
S-EPMC11890582 | biostudies-literature
UnknownInterferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.
Not available
S-EPMC4931749 | biostudies-literature
Sort   by:  
 Page size